PFPG
REGN icon

Pinnacle Financial Partners (Georgia)’s Regeneron Pharmaceuticals REGN Stock Holding History

Pinnacle Financial Partners (Georgia)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$505K Buy
809
+8
+1% +$5.45K ﹤0.01% 843
2026
Q1 		$619K Sell
801
-30
-4% -$23K ﹤0.01% 751
2025
Q4 		$642K Buy
+831
New +$564K ﹤0.01% 729

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Pinnacle Financial Partners (Georgia)'s REGN Position: Q2 2026 in Review

Pinnacle Financial Partners (Georgia) increased its Regeneron Pharmaceuticals (REGN) stake by 1% in Q2 2026, buying an estimated $5.45K and bringing the position to 809 shares worth $505K. The position accounts for ﹤0.01% of the portfolio, ranked #843.

Pinnacle Financial Partners (Georgia) first reported a position in REGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $642K in Q4 2025. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Pinnacle Financial Partners (Georgia) held 809 shares of Regeneron Pharmaceuticals worth $505K as of Q2 2026.
  • Pinnacle Financial Partners (Georgia) bought 8 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.45K.
  • Regeneron Pharmaceuticals made up ﹤0.01% of Pinnacle Financial Partners (Georgia)'s portfolio in Q2 2026, its #843 holding.
  • Pinnacle Financial Partners (Georgia) first reported a position in Regeneron Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • Pinnacle Financial Partners (Georgia)'s Regeneron Pharmaceuticals position peaked at $642K in Q4 2025.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Pinnacle Financial Partners (Georgia)'s 13F filing for Q2 2026, filed 14 Aug 2026.